Organization
Genrix (Shanghai) Biopharmaceutical
12 clinical trials
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Phase Ib Clinical Trial to Evaluate the Tolerability, Safety, Pharmacokinetics, Immunogenicity, and Preliminary Efficacy of GR2002 Injection in Patients With Moderate to Severe Atopic DermatitisStatus: Not yet recruiting, Estimated PCD: 2024-10-01
Clinical trial
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of GR2001 Injection in Healthy SubjectsStatus: Completed, Estimated PCD: 2023-11-01
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Clinical Trial to Evaluate the Efficacy and Safety of GR1802 Injection in Combination With Background Therapy in Patients With SAR.Status: Not yet recruiting, Estimated PCD: 2024-10-01
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Phase 3 Trial Evaluating the Efficacy, Safety, and Immunogenicity of GR1802 Injection in Patients With Moderate to Severe Atopic DermatitisStatus: Not yet recruiting, Estimated PCD: 2025-06-01
Clinical trial
A Randomized, Double-blind, Placebo-controlled, Single-dose Administration of GR2102 Injection in Healthy Adult Subjects to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity and Pharmacologic of GR2102Status: Not yet recruiting, Estimated PCD: 2025-01-06
Clinical trial
A Randomized, Double Blind, Placebo-Controlled Phase II Study to Evaluate the Efficacy, Safety of GR1802 Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)Status: Recruiting, Estimated PCD: 2024-10-30
Clinical trial
A Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Preliminary Efficacy, Safety, Pharmacokinetics and Immunogenicity Characteristics of GR1501 Injection by in Patients With Active Axial SpondyloarthritisStatus: Completed, Estimated PCD: 2021-07-30
Clinical trial
A Randomized, Double-blind, Placebo-controlled, Phase III Study of Efficacy and Safety of GR1501 in Patients With Radiographic Axial SpondyloarthritisStatus: Active (not recruiting), Estimated PCD: 2024-11-10
Clinical trial
A Phase Ⅰb/Ⅱ, Randomized, Double-blind, Placebo-controlled Study to Investigate the Tolerability, Safety,Pharmacokinetics and Efficacy of an Intravenous Treatment Regimen of GR1603 in Subjects With Systemic Lupus ErythematosusStatus: Recruiting, Estimated PCD: 2028-06-10
Clinical trial
An Open-label, Single-arm, Multicenter, Extension Study to Evaluate the Long-term Safety and Efficacy of GR1802 Injection in Patients With Chronic Rhinosinusitis With Nasal PolypsStatus: Not yet recruiting, Estimated PCD: 2024-12-30
Clinical trial
A Phase III Clinical Trail to Evaluate the Efficacy,Safety,Pharmacokinetics and Immunogenicity Characteristics of GR1801 Injection for the Post-exposure Prophylaxis (PEP) of WHO Category 3 Rabies Exposure Patients.Status: Recruiting, Estimated PCD: 2023-09-06
Clinical trial
A Phase I, Randomized, Blinding, Single-dose, Placebo Control Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics Effect of GR2002 in Chinese Health VolunteersStatus: Recruiting, Estimated PCD: 2023-11-30